Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer

References

• SiegelRLMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
   PubMed Web of Science ®Google Scholar
• ParkinDMFerlayJCuradoMPFifty years of cancer incidence: CI5 I-IXInt J Cancer2010127122918292721351270
   PubMed Web of Science ®Google Scholar
• StraussGMAdjuvant chemotherapy of lung cancer: methodologic issues and therapeutic advancesHematol Oncol Clin North Am200519226328115833406
   PubMedGoogle Scholar
• CaronMChoquet-KastylevskyGJoubert-CaronRCancer immunomics using autoantibody signatures for biomarker discoveryMol Cell Proteomics2007671115112217376768
   PubMed Web of Science ®Google Scholar
• FinnOJImmune response as a biomarker for cancer detection and a lot moreN Engl J Med2005353121288129016177255
   PubMed Web of Science ®Google Scholar
• BelousovPKuprashDNedospasovSShebzukhovYAutoantibodies to tumor-associated antigens as cancer biomarkersCurr Mol Med201010211512220196734
   PubMed Web of Science ®Google Scholar
• ZhongLCoeSPStrombergAJKhattarNHJettJRHirschowitzEAProfiling tumor-associated antibodies for early detection of non-small cell lung cancerJ Thorac Oncol20061651351917409910
   PubMed Web of Science ®Google Scholar
• MaLYueWTengYZhangLGuMWangYSerum anti-CCNY autoantibody is an independent prognosis indicator for postoperative patients with early-stage nonsmall-cell lung carcinomaDis Markers201335531732524167380
   PubMedGoogle Scholar
• BlixtOBuetiDBurfordBAutoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosisBreast Cancer Res2011132R2521385452
   PubMed Web of Science ®Google Scholar
• QiSHuangMTengHAutoantibodies to chromogranin A are potential diagnostic biomarkers for non-small cell lung cancerTumour Biol201536129979998526186986
   PubMedGoogle Scholar
• NiehrsCFunction and biological roles of the Dickkopf family of Wnt modulatorsOncogene200625577469748117143291
   PubMed Web of Science ®Google Scholar
• NiidaAHirokoTKasaiMDKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathwayOncogene200423528520852615378020
   PubMed Web of Science ®Google Scholar
• TianEZhanFWalkerRThe role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myelomaN Engl J Med2003349262483249414695408
   PubMed Web of Science ®Google Scholar
• LiSQinXGuoXDickkopf-1 is oncogenic and involved in invasive growth in non small cell lung cancerPLoS One2013812e8494424391982
   PubMed Web of Science ®Google Scholar
• RachnerTDThieleSGobelAHigh serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patientsBMC Cancer20141464925182503
   PubMed Web of Science ®Google Scholar
• HuangYYangXZhaoFOverexpression of Dickkopf-1 predicts poor prognosis for patients with hepatocellular carcinoma after orthotopic liver transplantation by promoting cancer metastasis and recurrenceMed Oncol201431796624878698
   PubMed Web of Science ®Google Scholar
• HanSXZhouXSuiXSerum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancerOncotarget2015623199071991726101916
   PubMedGoogle Scholar
• Voorzanger-RousselotNGoehrigDJourneFIncreased Dickkopf-1 expression in breast cancer bone metastasesBr J Cancer200797796497017876334
   PubMed Web of Science ®Google Scholar
• YaoXJiangHZhangCDickkopf-1 autoantibody is a novel serological biomarker for non-small cell lung cancerBiomarkers201015212813419839718
   PubMed Web of Science ®Google Scholar
• PengYHXuYWGuoHCombined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinomaCancer Med2016571388139626988995
   PubMedGoogle Scholar
• Rami-PortaRCrowleyJJGoldstrawPThe revised TNM staging system for lung cancerAnn Thorac Cardiovasc Surg20091514919262443
   PubMed Web of Science ®Google Scholar
• LiPShiJXDaiLPSerum anti-MDM2 and anti-c-Myc autoantibodies as biomarkers in the early detection of lung cancerOncoimmunology201655e113820027467958
   PubMedGoogle Scholar
• ZhangCYeLGuanSAutoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancerTumour Biol20143532047205124122232
   PubMedGoogle Scholar
• VoglFDFreyMKreienbergRRunnebaumIBAutoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian massBr J Cancer200083101338134311044359
   PubMed Web of Science ®Google Scholar
• MayerhoferKTempferCKuceraEHumoral p53 antibody response is a prognostic parameter in ovarian cancerAnticancer Res1999191B87587810216509
   PubMedGoogle Scholar
• AndersonKSWongJVitonisAp53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancerCancer Epidemiol Biomarkers Prev201019385986820200435
   PubMed Web of Science ®Google Scholar
• GoodellVSalazarLGUrbanNAntibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancerJ Clin Oncol200624576276816391298
   PubMed Web of Science ®Google Scholar
• GlinkaAWuWDeliusHMonaghanAPBlumenstockCNiehrsCDickkopf-1 is a member of a new family of secreted proteins and functions in head inductionNature199839166653573629450748
   PubMed Web of Science ®Google Scholar
• SatoNYamabukiTTakanoAWnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapyCancer Res201070135326533620551066
   PubMed Web of Science ®Google Scholar
• EdenfieldWJRichardsDAVukeljaSJA phase 1 study evaluating the safety and efficacy of DKN-01, an investigational monoclonal antibody (Mab) in patients (pts) with advanced non-small cell lung cancerJ Clin Oncol20143215_suppl80688068
   Google Scholar
• QianJZhengYZhengCActive vaccination with Dickkopf-1 induces protective and therapeutic antitumor immunity in murine multiple myelomaBlood2012119116116922049519
   PubMedGoogle Scholar
• QianJXieJHongSDickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myelomaBlood200711051587159417515399
   PubMed Web of Science ®Google Scholar
• TabuchiYShimodaMKagaraNProtective effect of naturally occurring anti-HER2 autoantibodies on breast cancerBreast Cancer Res Treat20161571556327113738
   PubMed Web of Science ®Google Scholar
• ChapmanCJHealeyGFMurrayAEarlyCDT(R)-Lung test: improved clinical utility through additional autoantibody assaysTumour Biol20123351319132622492236
   PubMed Web of Science ®Google Scholar